{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:29:12Z","timestamp":1792211352222,"version":"4.4.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672882"],"award-info":[{"award-number":["81672882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700555"],"award-info":[{"award-number":["81700555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770615"],"award-info":[{"award-number":["81770615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800564"],"award-info":[{"award-number":["81800564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872004"],"award-info":[{"award-number":["81872004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972747"],"award-info":[{"award-number":["81972747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002572"],"award-info":[{"award-number":["82002572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002967"],"award-info":[{"award-number":["82002967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070644"],"award-info":[{"award-number":["82070644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC1106800"],"award-info":[{"award-number":["2018YFC1106800"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.canlet.2022.215980","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T03:50:15Z","timestamp":1667533815000},"page":"215980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Circular RNAs in cholangiocarcinoma"],"prefix":"10.1016","volume":"553","author":[{"given":"Wenwei","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-8960","authenticated-orcid":false,"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215980_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10272","key":"10.1016\/j.canlet.2022.215980_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"Brindley","year":"2021","journal-title":"Cholangiocarcinoma. Nat Rev Dis Primers."},{"key":"10.1016\/j.canlet.2022.215980_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma: evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2022.215980_bib5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.annonc.2021.04.012","article-title":"Practical considerations in screening for genetic alterations in cholangiocarcinoma","volume":"32","author":"Bekaii-Saab","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2022.215980_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.canlet.2022.215980_bib7","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2018.01.033","article-title":"Patterns and trends of liver cancer incidence rates in eastern and southeastern Asian countries (1983-2007) and predictions to 2030","volume":"154","author":"Wu","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib8","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canlet.2022.215980_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"issue":"9935","key":"10.1016\/j.canlet.2022.215980_bib10","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"Razumilava","year":"2014","journal-title":"Cholangiocarcinoma. Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2022.215980_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/liv.14090","article-title":"Diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"39","author":"Macias","year":"2019","journal-title":"Liver Int."},{"issue":"4 Pt B","key":"10.1016\/j.canlet.2022.215980_bib12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bbadis.2017.08.002","article-title":"The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"1864","author":"Macias","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2022.215980_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6016931","article-title":"Clinical significance of preoperative serum CEA, CA125, and CA19-9 levels in predicting the resectability of cholangiocarcinoma","author":"Fang","year":"2019","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J. Hepatol."},{"issue":"14","key":"10.1016\/j.canlet.2022.215980_bib15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215980_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2022.215980_bib17","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.26577","article-title":"Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma","volume":"58","author":"Sulpice","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215980_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gdata.2016.01.012","article-title":"Gene expression profiling of the tumor microenvironment in human intrahepatic cholangiocarcinoma","volume":"7","author":"Sulpice","year":"2016","journal-title":"Genom Data"},{"key":"10.1016\/j.canlet.2022.215980_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Cholangiocarcinoma stem-like subset shapes tumorinitiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215980_bib20","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J. Hepatol."},{"issue":"22","key":"10.1016\/j.canlet.2022.215980_bib22","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2022.215980_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/hpb.12359","article-title":"Outcomes following resection of intrahepatic cholangiocarcinoma","volume":"17","author":"Tabrizian","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2022.215980_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2022.215980_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.suc.2013.12.004","article-title":"Distal cholangiocarcinoma","volume":"94","author":"Dickson","year":"2014","journal-title":"Surg Clin North Am"},{"issue":"24","key":"10.1016\/j.canlet.2022.215980_bib28","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215980_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215980_bib31","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","article-title":"Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures","volume":"73","author":"Sanger","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2022.215980_bib32","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1039\/C5MB00214A","article-title":"PredcircRNA: computational classification of circular RNA from other long non-coding RNA using hybrid features","volume":"11","author":"Pan","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.canlet.2022.215980_bib33","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1042\/CS20190940","article-title":"Exosomal circRNAs: new players in the field of cholangiocarcinoma","volume":"133","author":"Louis","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.canlet.2022.215980_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","article-title":"Circular RNAs in cancer: biogenesis, function, and clinical significance","volume":"6","author":"Li","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2022.215980_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mam.2019.10.006","article-title":"Circular RNAs: the star molecules in cancer","volume":"70","author":"Liu","year":"2019","journal-title":"Mol. Aspect. Med."},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2022.215980_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","article-title":"Translation and functional roles of circular RNAs in human cancer","volume":"19","author":"Lei","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.canlet.2022.215980_bib41","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1242\/dev.128074","article-title":"Circular RNAs: analysis, expression and potential functions","volume":"143","author":"Barrett","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.canlet.2022.215980_bib42","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines","volume":"130","author":"Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2022.215980_bib43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/hep.22838","article-title":"MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3","volume":"49","author":"Selaru","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.29832","article-title":"MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma","volume":"68","author":"Mansini","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-020-03346-4","article-title":"Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p\/BCL9L axis","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41419-018-0768-6","article-title":"Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma","volume":"9","author":"Yu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2022.215980_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-021-01482-9","article-title":"CircNFIB inhibits tumor growth and metastasis through suppressing MEK1\/ERK signaling in intrahepatic cholangiocarcinoma","volume":"21","author":"Du","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215980_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbrc.2018.01.077","article-title":"Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells","volume":"496","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.canlet.2022.215980_bib51","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/hep.32232","article-title":"IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13046-021-02095-2","article-title":"circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma","volume":"40","author":"Xu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/hep.31493","article-title":"A circular RNA, cholangiocarcinoma-associated circular RNA 1, contributes to cholangiocarcinoma progression, induces angiogenesis, and disrupts vascular endothelial barriers","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","article-title":"Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription","volume":"76","author":"Chen","year":"2022","journal-title":"J. Hepatol."},{"issue":"18","key":"10.1016\/j.canlet.2022.215980_bib55","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/CS20190589","article-title":"Circ-0000284 arouses malignant phenotype of cholangiocarcinoma cells and regulates the biological functions of peripheral cells through cellular communication","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib56","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.18632\/aging.101872","article-title":"Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma","volume":"11","author":"Xu","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib57","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/jcmm.16392","article-title":"Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2022.215980_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653207","article-title":"Circular RNA Circ0021205 promotes cholangiocarcinoma progression through MiR-204-5p\/RAB22A Axis","volume":"9","author":"Tu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"22","key":"10.1016\/j.canlet.2022.215980_bib59","first-page":"23251","article-title":"Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"15","key":"10.1016\/j.canlet.2022.215980_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00042-20","article-title":"Circular RNA CDR1as exerts oncogenic properties partially through regulating MicroRNA 641 in cholangiocarcinoma","volume":"40","author":"Li","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215980_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590478","article-title":"The emerging picture of the roles of CircRNA-CDR1as in cancer","volume":"8","author":"Jiang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib62","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41419-022-04534-0","article-title":"Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215980_bib63","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/OTT.S289241","article-title":"Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2","volume":"14","author":"Su","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2022.215980_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318795761","article-title":"Network analysesbased identification of circular ribonucleic acid-related pathways in intrahepatic cholangiocarcinoma","volume":"40","author":"Moirangthem","year":"2018","journal-title":"Tumour Biol"},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215980_bib66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.omtn.2020.06.025","article-title":"Whole-transcriptome sequencing identifies key differentially expressed mRNAs, miRNAs, lncRNAs, and circRNAs associated with CHOL","volume":"21","author":"Chu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4771","key":"10.1016\/j.canlet.2022.215980_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"4771","key":"10.1016\/j.canlet.2022.215980_bib68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2022.215980_bib69","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","article-title":"CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942","volume":"80","author":"Wong","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215980_bib70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbiotec.2016.09.011","article-title":"Circular RNAs are miRNA sponges and can be used as a new class of biomarker","volume":"238","author":"Kulcheski","year":"2016","journal-title":"J. Biotechnol."},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s13059-014-0409-z","article-title":"Expanded identification and characterization of mammalian circular RNAs","volume":"15","author":"Guo","year":"2014","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.canlet.2022.215980_bib72","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.molcel.2014.03.045","article-title":"Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance","volume":"54","author":"Denzler","year":"2014","journal-title":"Mol. Cell"},{"issue":"6357","key":"10.1016\/j.canlet.2022.215980_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/science.aam8526","article-title":"Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function","volume":"357","author":"Piwecka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.canlet.2022.215980_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/epi-2019-0295","article-title":"Circular RNA: biogenesis, degradation, functions and potential roles in mediating resistance to anticarcinogens","volume":"12","author":"Geng","year":"2020","journal-title":"Epigenomics"},{"issue":"8","key":"10.1016\/j.canlet.2022.215980_bib76","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.canlet.2022.215980_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215980_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","article-title":"Crosstalk between circRNAs and the PI3K\/AKT signaling pathway in cancer progression","volume":"6","author":"Xue","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.canlet.2022.215980_bib80","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.canlet.2022.215980_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2022.215980_bib82","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3748\/wjg.v16.i6.713","article-title":"Involvement of PI3K and ERK1\/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion","volume":"16","author":"Menakongka","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.canlet.2022.215980_bib83","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib85","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cancers11070926","article-title":"Wnt\/\u03b2-Catenin signaling in liver cancers","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib86","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI76452","article-title":"WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited","volume":"125","author":"Boulter","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/imm.12698","article-title":"Long non-coding RNA: a versatile regulator of the nuclear factor-\u03baB signalling circuit","volume":"150","author":"Mao","year":"2017","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.canlet.2022.215980_bib88","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2022.215980_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib90","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.canlet.2022.215980_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24003","article-title":"circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-\u03baB pathway","volume":"35","author":"Wu","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.canlet.2022.215980_bib92","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jhep.2014.09.007","article-title":"Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts","volume":"62","author":"Raggi","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215980_bib93","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1158\/0008-5472.CAN-12-2130","article-title":"Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma","volume":"73","author":"Mertens","year":"2013","journal-title":"Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2022.215980_bib94","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2022.215980_bib95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.canlet.2022.215980_bib96","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/1535370214532755","article-title":"Hypoxia-regulated gene network in drug resistance and cancer progression","volume":"239","author":"Lin","year":"2014","journal-title":"Exp Biol Med(Maywood)"},{"key":"10.1016\/j.canlet.2022.215980_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.canlet.2022.215980_bib98","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.7314\/APJCP.2014.15.14.5873","article-title":"High expression of HIF-1, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis","volume":"15","author":"Thongchot","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.canlet.2022.215980_bib99","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215980_bib100","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.510300522","article-title":"Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line","volume":"30","author":"Park","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215980_bib101","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2005.10.030","article-title":"Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes","volume":"44","author":"Meng","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215980_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2646148","article-title":"Epithelial-mesenchymal transition in pancreatic cancer: a review","volume":"2017","author":"Wang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2022.215980_bib103","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/CMAR.S239326","article-title":"CircHIPK3 promotes gemcitabine (GEM) resistance in pancreatic cancer cells by sponging miR-330-5p and targets RASSF1","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.canlet.2022.215980_bib104","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/CMAR.S255808","article-title":"Blocking circ_0013912 suppressed cell growth, migration and invasion of pancreatic ductal adenocarcinoma cells in vitro and in vivo partially through sponging miR-7-5p","volume":"12","author":"Guo","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12943-020-01300-8","article-title":"Expression profiles, biological functions and clinical significance of circRNAs in bladder cancer","volume":"20","author":"Yang","year":"2021","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2022.215980_bib106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma\u2014controversies and challenges[J]","volume":"8","author":"Patel","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.27050","article-title":"Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis","volume":"60","author":"Li","year":"2014","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"10.1016\/j.canlet.2022.215980_bib108","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"ESMO guidelines committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2022.215980_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/2159-8290.CD-16-1000","article-title":"Polyclonal secondary FGFR2 mutations drive acquired resistance to FGFR inhibition in patients with FGFR2 fusion-positive cholangiocarcinoma","volume":"7","author":"Goyal","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2022.215980_bib110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1200\/JCO.2017.75.5009","article-title":"Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma","volume":"36","author":"Javle","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2022.215980_bib111","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.canlet.2022.215980_bib113","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2022.215980_bib114","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2022.215980_bib115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12032-020-01373-x","article-title":"Circular RNAs and their participation in stemness of cancer","volume":"37","author":"Lagunas-Rangel","year":"2020","journal-title":"Med. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2022.215980_bib116","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1093\/nar\/gkz199","article-title":"FOXP1 circular RNA sustains mesenchymal stem cell identity via microRNA inhibition","volume":"47","author":"Cherubini","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2022.215980_bib117","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fphar.2018.00584","article-title":"Circular RNA signature predicts gemcitabine resistance of pancreatic ductal adenocarcinoma","volume":"9","author":"Shao","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2022.215980_bib118","article-title":"Circular RNA SMARCA5 correlates with favorable clinical tumor features and prognosis, and increases chemotherapy sensitivity in intrahepatic cholangiocarcinoma","volume":"34","author":"Lu","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"13","key":"10.1016\/j.canlet.2022.215980_bib119","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1021\/acs.chemrev.1c00009","article-title":"Thermostability, tunability, and tenacity of RNA as rubbery anionic polymeric materials in nanotechnology and nanomedicine-specific cancer targeting with undetectable toxicity","volume":"121","author":"Binzel","year":"2021","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.canlet.2022.215980_bib120","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/acs.accounts.9b00272","article-title":"Nanostructured materials for intracellular cargo delivery","volume":"52","author":"Tay","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.canlet.2022.215980_bib121","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41565-017-0012-z","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.canlet.2022.215980_bib122","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.canlet.2022.215980_bib123","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2022.215980_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108123","article-title":"Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer","volume":"234","author":"Wang","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.canlet.2022.215980_bib125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1039\/D1NR04411G","article-title":"Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models","volume":"14","author":"Kumar","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2022.215980_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.694838","article-title":"RNA interference and nanotechnology: a promising alliance for next generation cancer therapeutics[J]","volume":"3","author":"Swaminathan","year":"2021","journal-title":"Frontiers in Nanotechnology"},{"issue":"8","key":"10.1016\/j.canlet.2022.215980_bib127","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/cancers11081164","article-title":"Evolving clinical utility of liquid biopsy in gastrointestinal cancers","volume":"11","author":"Jacobson","year":"2019","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.canlet.2022.215980_bib128","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MPA.0000000000001662","article-title":"Reviews on current liquid biopsy for detection and management of pancreatic cancers","volume":"49","author":"Kaczor-Urbanowicz","year":"2020","journal-title":"Pancreas"},{"issue":"8","key":"10.1016\/j.canlet.2022.215980_bib129","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/cancers11081152","article-title":"Liquid biopsy as surrogate for tissue for molecular profiling in pancreatic cancer: a meta-analysis towards precision medicine","volume":"11","author":"Luchini","year":"2019","journal-title":"Cancers"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522004670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:07:05Z","timestamp":1759594025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522004670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":129,"alternative-id":["S0304383522004670"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215980","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNAs in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"215980"}}